|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
Chemistry
| Test | 30-JUL-2022 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | 4.8 - 5.9 | % |
| Glucose [Mass/volume] in Blood | 96.0 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 18.3 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.8 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.4 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.9 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.4 | 3.5 - 5.3 | mmol/L |
| Chloride [Moles/volume] in Blood | 107.1 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 21.3 L | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 142.5 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 141.6 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 83.6 | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 30.5 L | 40 - 60 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 8.7 | 0 - 30 | mg/g |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| Most parameters are within normal limits. Notable findings include mildly elevated chloride, low total CO₂ (suggesting possible mild metabolic acidosis), and low HDL cholesterol, which is a cardiovascular risk factor. Renal function and glycemic control are normal. Recommend clinical correlation for acid-base status and consideration of cardiovascular risk management due to low HDL. |